Assignee
STOKE THERAPEUTICS INC
US·8 granted patents·17 pending applications·26 citations·filing 2018–2025
Top patents by PatentIndex Score
25 records- 0194US11096956B2Antisense oligomers and uses thereofSTOKE THERAPEUTICS INC·Filed 2018·Granted Aug 24, 2021·11 cites·20 claims
- 0290US11873490B2Antisense oligomers for treatment of conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2020·Granted Jan 16, 2024·2 cites·19 claims
- 0390US10683503B2Antisense oligomers for treatment of conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2019·Granted Jun 16, 2020·6 cites·62 claims
- 0489US11814622B2OPA1 antisense oligomers for treatment of conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2023·Granted Nov 14, 2023·1 cites·21 claims
- 0589US10913947B2Antisense oligomers for treatment of conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2019·Granted Feb 9, 2021·6 cites·79 claims
- 0681US2024150760A1Antisense oligomers for treatment of conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0776US2024102011A1Opa1 antisense oligomers for treatment of conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0869US12338437B2OPA1 antisense oligomers for treatment of conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2021·Granted Jun 24, 2025·0 cites·20 claims
- 0969US2024033378A1Antisense oligomers for treatment of non-sense mediated rna decay based conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1068US2025059535A1Opa1 antisense oligomers for treatment of conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1167US2024254488A1Antisense oligomers for treatment of non-sense mediated rna decay based conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1266US2024117353A1Compositions for treatment of conditions and diseases associated with polycystin expressionSTOKE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1365US2026035694A1Antisense oligomers for treatment of non-sense mediated rna decay based conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1465US2022118000A1Antisense oligomers and uses thereofSTOKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1559US2022290142A1Compositions and methods for modulating splicing and protein expressionSTOKE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1658US12577561B2Antisense oligomers for treatment of conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2021·Granted Mar 17, 2026·0 cites·17 claims
- 1758US2022127612A1Methods and compositions for modulating splicing and translationSTOKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1857US2026055409A1Compounds and methods for treating human subjectsSTOKE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1954US2023116704A1Antisense oligomers for treatment of conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2053US2025388902A1Antisense oligomers for treatment of non-sense mediated rna decay based conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2153US2022162599A1Methods and compositions for modulating splicing of alternative intronsSTOKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2253US2025066781A1Methods for treating conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2352US2021268667A1Antisense oligomers for treatment of non-sense mediated rna decay based conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2449US12060558B2Methods and compositions for treatment of cholesteryl ester storage diseaseSTOKE THERAPEUTICS INC·Filed 2019·Granted Aug 13, 2024·0 cites·18 claims
- 2544US2025243493A1Compounds for treatment of conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when STOKE THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →